Financials
Financial year 2025
Revenue
€ 7.9 million
▼ 11% vs 2024
Profit
Healthy€ 301,639
▼ 5% vs 2024
Debts
Low€ 867,242
▼ 29% vs 2024
Abbott Rapid Diagnostics from Zaventem, company number BE0455002056, closed financial year 2025 with a result of € 301,639 after tax. For that financial year Abbott Rapid Diagnostics recorded revenue of € 7.9 million and equity of € 7.1 million. Compared with financial year 2024, the result moved from € 317,389 to € 301,639. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
What happened at Abbott Rapid Diagnostics?
What happened at Abbott Rapid Diagnostics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 301,639 (▼ 5% vs 2024). Source: NBB ↗
- Demaerschalk Tim became a director. NBB
- Hendrikus Lueb stepped down as director. NBB
- Hendrikus Lueb became a director. NBB
- New establishment in Zaventem. KBO
- Start of the company according to the CBE. KBO
In short
From € 543,351 profit in 2021 to € 301,639 profit in 2025.
Paid € 715,050 in corporate taxes since 2021.
Best year ever: 2021, with € 543,351 profit.
On average € 346,100 of value added per employee in 2021.
A new publication or filing at Abbott Rapid Diagnostics? We notify you, reason included.
Follow Abbott Rapid DiagnosticsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Abbott Rapid Diagnostics is Demaerschalk Tim. The shares are held by Abbott SA (100%).
Directors
According to the 2025 annual accounts
Demaerschalk Tim
Director
since 2026
Hendrikus Lueb
Director
since 2017 · until 2026
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 11 box F1
1930 Zaventem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
Abbott Belgian Pension Fund
ABBOTT MEDICAL BELGIUM
€ 85.5 million revenue · 2025
GARTNER BELGIUM
€ 54.2 million revenue · 2025
TMC Science & Technology
€ 41.8 million revenue · 2025
OPEN PIXEL SYSTEMS
€ 449,625 gross margin · 2025
+1 more
Website
Canonical: https://www.cardiovascular.abbott/int/en/hcp/products/cardiac-rhythm-management/cardiac-resynchronization-therapy.html
Technologies
Domain
Domain
nextlevelcrt.eu
Registrar
CSC CORPORATE DOMAINS INC.
Website info
Features
Details
- Company number
- 0455.002.056
- VAT number
- BE 0455.002.056
- Registered office
- Da Vincilaan 11 bus F1, 1930 Zaventem
- Names & denominations
- Abbott Rapid Diagnostics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 April 1995
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- nextlevelcrt.eu
- Activities · NACE
Groothandel in farmaceutische en medische artikelen